Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $353.92 | $19.37 | 1,727.29% | 7,078.40x | 104.48x | 7.84x | 9.49x | 6.83x | $529.27M | 1.36% | $4.13B | 37.48 | $37.07B | 116.57 | ||
| NVO | NOVO NORDISK A S | $47.64 | $149.88 | -68.21% | 13.06x | 2.09x | 4.35x | 6.93x | 0.14x | $9.33B | 4.38% | $30.70B | 6.88 | $229.25B | 9.50 | ||
| CORT | CORCEPT THERAPEUTICS INC | $40.83 | $41.86 | -2.45% | 40.83x | 65.98x | 5.70x | 6.80x | 0.42x | $162.57M | 3.85% | $631.90M | 6.10 | $4.18B | 63.30 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $43.09 | $17.79 | 142.22% | 87.94x | 27.01x | 5.38x | 6.10x | 1.06x | $101.73M | 3.16% | $535.38M | 7.17 | $3.10B | 57.88 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.60 | $16.51 | -47.91% | 17.92x | 15.19x | 5.70x | 3.64x | 0.23x | -$23.64M | -4.92% | $133.17M | 2.38 | $492.44M | 7.33 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $328.16 | $36.91 | 788.97% | 1,058.58x | 48.99x | 13.44x | 185.36x | 3.44x | $221.36M | 0.51% | $233.89M | 1.78 | $45.08B | 296.71 | ||
| VCEL | VERICEL CORP | $36.19 | $9.61 | 276.59% | 139.19x | 63.85x | 7.06x | 5.69x | 1.64x | $20.38M | 1.12% | $321.86M | 6.38 | $1.83B | 62.36 | ||
| ARGX | ARGENX SE | $811.45 | $371.91 | 118.19% | 32.43x | 27.07x | 26,175.81x | 6.91x | 1.31x | $467.72M | 0.94% | $7.17B | 117.50 | $47.12B | 58.08 | ||
| GMAB | GENMAB A | $30.90 | $128.48 | -75.95% | 13.19x | 1.83x | 5.57x | 3.45x | 0.10x | $1.19B | 6.02% | $5.75B | 8.96 | $18.22B | 9.11 | ||
| KRYS | KRYSTAL BIOTECH INC | $272.74 | $119.55 | 128.14% | 39.53x | 32.75x | 21.16x | 6.95x | 1.26x | $166.02M | 2.10% | $1.14B | 39.30 | $7.53B | 38.93 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $190.44 | $72.64 | 162.17% | 82.44x | 22.51x | 14.84x | 3.94x | 1.18x | $30.76M | 0.82% | $950.17M | 48.53 | $4.06B | 39.41 | ||
| TECH | BIO-TECHNE CORP | $66.78 | $16.53 | 304.09% | 128.42x | 33.06x | 8.56x | 5.20x | 1.82x | $223.02M | 2.14% | $2.01B | 12.90 | $10.63B | 46.93 | ||
| ADMA | ADMA BIOLOGICS INC | $16.43 | $12.80 | 28.36% | 18.67x | 18.00x | 8.02x | 9.07x | 0.78x | $40.73M | 1.04% | $431.19M | 1.81 | $3.92B | 22.79 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.13 | $19.20 | -73.29% | 3.23x | -95.18x | 732.86x | 1.62x | 0.19x | -$82.36M | -29.59% | $171.23M | 3.16 | $218.89M | 2.44 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $5.20 | $4.34 | 19.69% | 19.26x | 17.28x | 3.33x | 5.87x | 0.69x | $21.15M | 5.10% | $70.68M | 0.89 | $353.76M | 15.59 | ||
| RPRX | ROYALTY PHARMA PLC | $44.65 | $47.15 | -5.31% | 25.37x | 8.61x | 8.21x | 2.68x | 0.44x | $2.11B | 10.95% | $9.62B | 22.28 | $33.78B | 32.35 | ||
| VCYT | VERACYTE INC | $36.19 | $12.50 | 189.59% | 92.79x | 32.03x | 5.75x | 2.27x | 1.30x | $98.21M | 3.45% | $1.26B | 15.98 | $2.58B | 45.34 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.44 | $9.90 | 45.92% | 24.90x | 15.14x | 7.16x | 5.20x | 0.81x | $119.87M | 6.30% | $365.77M | 2.78 | $1.91B | 18.44 | ||
| MNKD | MANNKIND CORP | $5.78 | $2.95 | 96.21% | 57.80x | 66.21x | 5.65x | -39.84x | 0.90x | $43.39M | 2.44% | -$44.55M | -0.15 | $2.01B | 27.43 | ||
| XOMA | XOMA ROYALTY CORP | $24.86 | $15.92 | 56.11% | 30.69x | 79.07x | 6.41x | 3.50x | 0.81x | -$12.41M | -4.11% | $87.94M | 7.25 | $349.28M | 13.06 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.89 | $3.59 | -19.53% | 41.29x | 16.35x | 3.71x | 4.39x | 0.33x | -$11.69M | -5.09% | $52.91M | 0.67 | $226.95M | 25.58 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $477.92 | $191.60 | 149.43% | 33.40x | 23.44x | 10.42x | 7.00x | 1.62x | $3.34B | 2.73% | $17.32B | 67.76 | $118.15B | 25.34 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.27 | $63.65 | -41.44% | 11.54x | 8.62x | 2.60x | 2.57x | 0.31x | $296.89M | 13.84% | $835.12M | 14.51 | $1.67B | 6.19 | ||
| HALO | HALOZYME THERAPEUTICS INC | $81.23 | $81.62 | -0.48% | 16.61x | 9.75x | 7.66x | 18.96x | 0.56x | $602.40M | 6.33% | $503.92M | 4.30 | $10.64B | 12.59 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.13 | $51.56 | 12.75% | 21.37x | 13.11x | 3.61x | 1.84x | 0.60x | $832.13M | 7.45% | $6.06B | 31.54 | $10.51B | 13.61 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.44 | $23.62 | 3.49% | 13.65x | 13.46x | 5.18x | 3.26x | 0.68x | $234.54M | 7.83% | $920.25M | 7.51 | $2.32B | 7.15 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $23.49 | $6.18 | 279.94% | 67.11x | -20.44x | 2.92x | 7.41x | 2.08x | $78.64M | 2.65% | $401.17M | 3.17 | $2.97B | 31.77 | ||
| EXEL | EXELIXIS INC | $43.90 | $36.55 | 20.12% | 17.85x | 13.51x | 5.15x | 5.45x | 0.72x | $779.77M | 6.62% | $2.16B | 8.05 | $11.57B | 12.47 | ||
| CRMD | CORMEDIX INC | $7.69 | $14.61 | -47.36% | 3.39x | 4.73x | 2.73x | 1.62x | 1.89x | $74.42M | 12.74% | $374.13M | 4.93 | $706.32M | 6.29 | ||
| INVA | INNOVIVA INC | $21.80 | $19.49 | 11.83% | 11.53x | 9.98x | 3.87x | 1.61x | 0.94x | $196.54M | 13.06% | $1.01B | 14.63 | $1.41B | 6.57 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $785.51 | $448.42 | 75.17% | 18.24x | 16.91x | 5.73x | 2.66x | 1.45x | $4.08B | 4.97% | $31.26B | 298.82 | $82.63B | 14.20 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $23.56 | $12.24 | 92.47% | 15.01x | 30.80x | 3.80x | 4.35x | 2.74x | $197.81M | 4.97% | $917.27M | 5.43 | $3.76B | 13.07 | ||
| UTHR | UNITED THERAPEUTICS CORP | $485.36 | $256.38 | 89.31% | 17.04x | 16.47x | 6.80x | 3.17x | 1.95x | $1.12B | 5.28% | $6.59B | 150.46 | $19.56B | 11.03 | ||
| INCY | INCYTE CORP | $108.39 | $76.85 | 41.04% | 17.95x | 13.54x | 4.41x | 4.58x | 0.95x | $1.20B | 5.64% | $4.65B | 23.77 | $18.86B | 11.21 | ||
| MDXG | MIMEDX GROUP INC | $5.15 | $2.70 | 90.97% | 18.39x | 45.90x | 1.94x | 3.19x | 1.76x | $66.82M | 8.76% | $238.95M | 1.61 | $638.86M | 9.23 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.